期刊文献+

固相金属亲和层析纯化全长人PPARγ重组蛋白

Purification of Full Length Human PPARγRecombinant Protein by Immobilized Metal-ion Affinity Chromatography
原文传递
导出
摘要 建立全长人PPARγ重组蛋白的固相金属亲和层析纯化方法。利用E.coli BL_(21)(DE3)细胞外源性表达出全长人PPARγ重组蛋白,采用固相金属亲和层析法纯化目标蛋白。通过考察咪唑浓度对纯化的影响,确定在8 mol/L尿素下,用含50 mmol/L咪唑的缓冲液冲洗,200mmol/L咪唑缓冲液洗脱,可获得纯度为95%的目标蛋白,透析复性后经放射配体受体饱和结合实验测定全长人PPARγ重组蛋白的解离常数K_d为106±6nmol/L。结果表明本文所建立的方法能够成功纯化出高纯度的目标蛋白,经复性后,可获得用于结构和功能研究的全长人PPARγ重组蛋白。 A strategy for purification full length human peroxisome proliferator activated receptor-γ(PPARγ)was developed by immobilized metal-ion affinity chromatography. The full length human PPAR7 Recombinant Protein was expressed by E. coli BL21 (DE3) ;and purification was carried out by immobilized metal-ion affinity chromatography. The conditions: 50mmol/L imidazole in washing buffer and 200mmol/L imidazole in elution buffer with 8mol/L Urea,that was optimized by examining imidazole concentration. 95% purity of the full length PPARγ was obtained by one-step purification with IMAC. After dialysis refolded ,the activity was tested with radio-ligand receptor binding assay and the Kd was 106 ± 6nmol/L. These results demonstrate that the strategy here can be used to produce biologically activie full length human PPARγ recombinant protein for the investigation of structure and function.
出处 《光谱实验室》 CAS 2013年第2期882-886,共5页 Chinese Journal of Spectroscopy Laboratory
基金 国家自然科学基金资助项目(30772595)
关键词 固相金属亲和层析 全长人过氧化物酶体增殖物激活受体γ 活性 Immobilized Metal-ion Affinity Chromatography Full Length Human PPARγ Activity
  • 相关文献

参考文献10

  • 1Porath J. Immobilized Metal Ion Affinity Chromatography[J]. Protein Expr. Purif. , 1992,3(4) : 263--281.
  • 2Birko Z,Schauwecker F. Pfennig F et al. Expression and Rapid One-Step Purl? cation of Biologically Active His-Tagged Factor C by Niz+ Affinity Column Chromatography[J]. FEMS Microbiol. Left. , 2001,196(2) :223--227.
  • 3Fajas L,Auboeuf D,Raspe E et al. The Organization,Promoter Analysis,and Expression of the Human PPARY Gene[J]. J. Biol. Chem: 1997,272 (30) : 18779--18789.
  • 4Nuclear Receptors Nomenclature Committee. A Unified Nomenclature System for the Nuclear Receptor Superfamily[J]. Cell, 1999, 97(2) 161--163.
  • 5Bapat A R,Frail D E. Fun-Length Estrogen Receptor Alpha and Its Ligand-Binding Domain Adopt Different Conformations Upon Binding Ligand[J]. J. Steroid Biochem. and Mol. Biol. ,2003,86(2) :143--149.
  • 6Berbaum J,Harrison R K. Comparison of Full Length Versus Ligand Binding Domain Constructs in Cell-Free and Cell-Based Peroxisome Proliferators-Activated Receptor Alpha Assays[J ]. Anal. Biochem. ,2005,339(1).'121--128.
  • 7Bradord M M,Mcrorie R , Williams W L. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding[J]. Anal. Biochem. , 1976,72(1--2) :248--254.
  • 8LaemmLin U K. Cleavage of Structural Proteins During the Assembly of the Head of Bacteriophage T4 [J]. Nature, 1970,227 (5259) : 680--685.
  • 9Lehmann J M,Moore L B,Smith-Oliver R A et al. An Antidiabetic Thiazolidinedione is a High Affinity Ligand for Peroxisome Proliferator-Activated Receptor 7 (PPAR)')[J]. ,1. Biol. Chem. , 1995,270(22) 12953--12956.
  • 10Ferry G, Bruneau V, Beauverger Pet al. Binding of Prostaglandins to Human PPARY: Toolassessment and Newnaturalligands[J]. Eur:I. Pharmacol: 2001,417 (1--2) : 77--89.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部